These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8328786)

  • 61. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.
    Silva JJ; Osakabe AL; Pavanelli WR; Silva JS; Franco DW
    Br J Pharmacol; 2007 Sep; 152(1):112-21. PubMed ID: 17603548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Different forms of administration of biotherapy 7dH in mice experimentally infected by Trypanosoma cruzi produce different effects.
    Ferraz FN; Simoni GK; do Nascimento A; de Melo CS; Aleixo DL; Gomes ML; Spack M; de Araújo SM
    Homeopathy; 2011 Oct; 100(4):237-43. PubMed ID: 21962198
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study.
    Mazzeti AL; Diniz LF; Gonçalves KR; Nascimento AFS; Spósito PAF; Mosqueira VCF; Machado-Coelho GLL; Ribeiro I; Bahia MT
    Biochem Pharmacol; 2018 Feb; 148():213-221. PubMed ID: 29309767
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.
    Back DJ; Stevenson P; Tjia JF
    Br J Clin Pharmacol; 1989 Aug; 28(2):166-70. PubMed ID: 2775622
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chemotherapy of Chagas' disease: the how and the why.
    Urbina JA
    J Mol Med (Berl); 1999 Mar; 77(3):332-8. PubMed ID: 10090596
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interaction of terbinafine with human serum and serum proteins.
    Ryder NS; Frank I
    J Med Vet Mycol; 1992; 30(6):451-60. PubMed ID: 1287164
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.
    Urbina JA; McKerrow JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7923-4. PubMed ID: 26578701
    [No Abstract]   [Full Text] [Related]  

  • 68. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
    Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
    Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7925. PubMed ID: 26578702
    [No Abstract]   [Full Text] [Related]  

  • 71. Primaquine is lethal for intracellular but not extracellular Trypanosoma cruzi.
    McCabe RE
    J Parasitol; 1988 Oct; 74(5):748-53. PubMed ID: 3138394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.
    Planer JD; Hulverson MA; Arif JA; Ranade RM; Don R; Buckner FS
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2977. PubMed ID: 25033456
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.
    Ryder NS
    Antimicrob Agents Chemother; 1985 Feb; 27(2):252-6. PubMed ID: 4039119
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection.
    Engel JC; Doyle PS; Hsieh I; McKerrow JH
    J Exp Med; 1998 Aug; 188(4):725-34. PubMed ID: 9705954
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
    Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lychnopholide in Poly(d,l-Lactide)-
    Branquinho RT; de Mello CGC; Oliveira MT; Reis LES; Vieira PMA; Saúde-Guimarães DA; Mosqueira VCF; de Lana M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988096
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The dog as model for chemotherapy of the Chagas' disease.
    Guedes PM; Veloso VM; Tafuri WL; Galvão LM; Carneiro CM; Lana Md; Chiari E; Ataide Soares K; Bahia MT
    Acta Trop; 2002 Oct; 84(1):9-17. PubMed ID: 12387906
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis, activity, and molecular modeling studies of 1,2,3-triazole derivatives from natural phenylpropanoids as new trypanocidal agents.
    de Souza TB; Caldas IS; Paula FR; Rodrigues CC; Carvalho DT; Dias DF
    Chem Biol Drug Des; 2020 Jan; 95(1):124-129. PubMed ID: 31569301
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
    Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
    Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction of resistance to azole drugs in Trypanosoma cruzi.
    Buckner FS; Wilson AJ; White TC; Van Voorhis WC
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3245-50. PubMed ID: 9835521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.